A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome

Sleep Medicine

Volumn 8, Issue 7-8, 2007, Pages 742-752

  Garcia Borreguero, Diego ^a   Grunstein, Ronald ^b   Sridhar, Guruswamy ^c   Dreykluft, Tilman ^d   Montagna, Pasquale ^e   Dom, René ^f   Lainey, Eric ^g   Moorat, Anne ^h   Roberts, James ^h  

^a SLEEP RESEARCH INSTITUTE   (Spain)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c REGINA GENERAL HOSPITAL   (Canada)

^d Klinische Forschung Berlin Buch   (Germany)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^h GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Efficacy; Long term safety; Open label clinical trial; Quality of life; Restless legs syndrome; Ropinirole; Sleep

Indexed keywords

ROPINIROLE;

ABDOMINAL PAIN; ADULT; AGED; ARTHRALGIA; ARTICLE; BACKACHE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FIBROSIS; FLU LIKE SYNDROME; HEART INFARCTION; HUMAN; INTRACRANIAL HYPERTENSION; LIBIDO DISORDER; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE CRAMP; NAUSEA; OPEN STUDY; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; RHINOPHARYNGITIS; SCORING SYSTEM; SKIN DEFECT; SLEEP; SOMNOLENCE; STOMACH DISCOMFORT; THORAX PAIN; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; DOPAMINE AGONISTS; FEMALE; HUMANS; INDOLES; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RESTLESS LEGS SYNDROME; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 35048813646     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2006.09.009     Document Type: Article

References (42)

1. Hening W., Walters A.S., Allen R.P., et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 5 (2004) 237-246
2. Michaud M., Paquet J., Lavigne G., et al. Sleep laboratory diagnosis of restless legs syndrome. Eur Neurol 48 (2002) 108-113
3. Allen R.P., and Earley C.J. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 18 (2001) 128-147
4. McParland P., and Pearce J.M. Restless legs syndrome in pregnancy. Case reports. Clin Exp Obstet Gynecol 17 (1990) 5-6
5. Goodman J.D., Brodie C., and Ayida G.A. Restless leg syndrome in pregnancy. BMJ 297 (1988) 1101-1102
6. O'Keeffe S.T., Gavin K., and Lavan J.N. Iron status and restless legs syndrome in the elderly. Age Ageing 23 (1994) 200-203
7. Sun E.R., Chen C.A., Ho G., et al. Iron and the restless legs syndrome. Sleep 21 (1998) 371-377
8. Winkelman J.W., Chertow G.M., and Lazarus J.M. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis 28 (1996) 372-378
9. Collado-Seidel V., Kohnen R., Samtleben W., et al. Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis 31 (1998) 324-328
10. Ulfberg J., Nystrom B., Carter N., et al. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord 16 (2001) 1159-1163
11. Rothdach A.J., Trenkwalder C., Haberstock J., et al. Prevalence and risk factors of RLS in an elderly population. The MEMO study. Neurology 54 (2000) 1064-1068
12. Phillips B., Young T., Finn L., et al. Epidemiology of restless legs symptoms in adults. Arch Int Med 160 (2000) 2137-2141
13. Ulfberg J., Nystrom B., Carter N., et al. Restless legs syndrome among working-aged women. Eur Neurol 46 (2001) 17-19
14. Allen R., Picchietti D., Hening W., et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4 (2003) 101-119
15. Abetz L., Allen R., Follet A., et al. Evaluating the quality of life of patients with restless legs syndrome. Clin Ther 26 (2004) 925-935
16. Collado-Seidel V., Winkelmann J., and Trenkwalder C. Aetiology and treatment of restless legs syndrome. CNS Drugs 12 (1999) 9-20
17. Chesson A.L., Wise M., Davila D., et al. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 22 (1999) 961-968
18. Silber M.H., Ehrenberg B.L., Allen R.P., et al. An algorithm for the management of restless legs syndrome. Mayo Clin Proc 79 (2004) 916-922
19. Littner M., Kushida C., McDowell Anderson W., et al. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 27 (2004) 557-559
20. Brodeur C., Montplaisir J., Godbout R., et al. Treatment of restless legs syndrome and periodic movements during sleep with l-dopa: a double-blind, controlled study. Neurology 38 (1988) 1845-1848
21. Montplaisir J., Godbout R., Poirier G., et al. Restless legs syndrome and periodic movements in sleep: physiopathology and treatment with l-dopa. Clin Neuropharmacol 9 (1986) 456-463
22. Allen R.P., and Earley C.J. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 19 (1996) 205-213
23. Hening W.A., Allen R.P., Earley C.J., et al. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 27 (2004) 560-583
24. Stiasny K., Wetter T.C., Trenkwalder C., et al. Restless legs syndrome and its treatment by dopamine agonists. Parkinsonism Relat Disord 7 (2001) 21-25
25. Stiasny K., Wetter T.C., Winkelmann J., et al. Long-term effects of pergolide in the treatment of restless legs syndrome. Neurology 56 (2001) 1399-1402
26. Wetter T.C., Stiasny K., Winkelmann J., et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 52 (1999) 944-950
27. Pritchett A.M., Morrison J.F., Edwards W.D., et al. Valvular heart disease in patients taking pergolide. Mayo Clin Proc 77 (2002) 1280-1286
28. Danoff S.K., Grasso M.E., Terry P.B., et al. Pleuropulmonary disease due to pergolide use for restless legs syndrome. Chest 120 (2001) 313-316
29. Trenkwalder C., Garcia-Borreguero D., Montagna P., et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 75 (2004) 92-97
30. Walters A.S., Ondo W.G., Dreykluft T., et al. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord 19 (2004) 1414-1423
31. Allen R., Becker P.M., Bogan R., et al. Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome. Sleep 27 (2004) 907-914
32. Montplaisir J., Nicolas A., Denesle R., et al. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 52 (1999) 938-943
33. Montplaisir J., Denesle R., and Petit D. Pramipexole in the treatment of restless legs syndrome: a follow-up study. Eur J Neurol 7 Suppl. 1 (2000) 27-31
34. Saletu M., Anderer P., Saletu-Zyhlarz G., et al. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome. Eur Arch Psychiatry Clin Neurosci 252 (2002) 185-194
35. Stiasny-Kolster K., and Oertel W.H. Low-dose pramipexole in the management of restless legs syndrome. An open label trial. Neuropsychobiology 50 (2004) 65-70
36. Bogan R., Connolly M.G., and Rederich G. Ropinirole is an effective, well-tolerated treatment for moderate or severe RLS: results of TREAT RLS US, a 12-week, randomized, double-blind, placebo-controlled US trial. Neurology 64 6, Suppl. 1 (2005) S04.002, A27
37. Ziman R., Watson C.B., and Bogan R.K. Onset of symptom improvement within 2 nights in patients with restless legs syndrome (RLS) treated with ropinirole. Neurology 66 Suppl. 2 (2006) A82:P02.028
38. Montplaisir J., Karrasch J., Haan J., and Volc D. Ropinirole is effective in the long-term management of restless legs syndrome: A randomized controlled trial. Mov Disord (2006) Epub ahead of print
39. Kelly M., and Mistry P. Ropinirole markedly reduces periodic leg movements during sleep (PLMS) in patients with RLS. Eur J Neurol 11 Suppl. 2 (2004) 111:P1291
40. Winkelman J.W., and Johnston L. Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS). Sleep Med 5 (2004) 9-14
41. Dodd M.L., Klos K.J., Bower J.H., et al. Pathological gambling caused by drugs used to treat Parkinson's disease. Arch Neurol 62 (2005) 1-5
42. Avanzi M., Uber E., and Bonfa F. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease. Neurol Sci 25 (2004) 98-101